Abstract
Purpose: To study the influence of the calcium channel blocker verapamil on the development of glaucoma in the adrenalin-induced experimental model of glaucoma. Methods: In the experimental model, glaucoma was induced in albino rabbits by repeated injections of small doses of adrenalin. The criteria for experimental glaucoma were (1) increased IOP, (2) decreased outflow and (3) decreased blood supply to the eye. One group with advanced glaucoma served as a control. In the other 3 groups, instillations of 0.25% verapamil were applied at different stages of the glaucomatous process. Results: Verapamil blocked the development of experimental glaucoma when applied concurrently with the adrenalin injections, and instillations at the initial or advanced stages of the disease stabilized the progression of glaucoma. Conclusion: We demonstrate that mechanisms involving adrenalin and calcium are involved in glaucoma and that the use of calcium channel blockers is most effective in the early stages of the glaucomatous process.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Krizhanovsky GN, Kashintseva LT, Lipovetskaya EM, Kopp OP. The role of adrenoreception in the development of primary glaucoma. Oftalmol Zh 1981; 9: 292–295 (Ukraine).
Rasmussen H, Kelley G, Douglas JS. Interactions between Ca2+ and cAMP messenger system in regulation of airway smooth muscle contraction. Amer J Physiol 1990; 258: 279–288.
Reuter H. Modulation of ion channels by phosphorylation and second messengers. News Physiol Sci 1987; 2: 167–171.
Krizhanovsky GN, Kashintseva LT, Mikheytseva IN, Lipovetskaya EM, Kopp OP. The cyclic nucleotides in experimental glaucoma. Byull Eksp Biol i Med 1988; 10: 419–421 (Russia).
Houslay M. “Crosstalk”: a pivotal role for proteinkinase C in modulating relationships between signal transduction pathways. Europ J Biochem 1991; 19511: 2–27.
Jurevicus J, Fischmeister R. CAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by β-adrenergic agonists. Proc Natl Acad Sci USA 1996; 93: 295–299.
Abelson M, Gilbert M, Smith L. Sustained reduction of intraocular pressure in humans with the calcium channel blocker Verapamil. Am J Ophthalmol 1988; 105: 155–159.
Kitazawa Y, Shirai H, Go FJ. The effect of Ca2+ antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1989; 227: 408–412.
Serie JB, Schmidt KJ, Mittag TW, Schumer RA. Podos SM, Camras CB. Nifidipine and ocular blood flow. Invest Ophthalmol Vis Sci 1992; 33 (suppl.): 1279.
Hitchings RA. Therapeutic rational for normal tension glaucoma. Curr Opin Ophthalmol 1995; 2: 67–70.
Hitchings RA, O'Brein, O'Sullivan. Intraocular pressure and circulation at the disc in glaucoma. Acta Ophthalmol Scand 1997; 75 (Suppl.): 15–22.
Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol 1993; 15: 608–613.
Pillunat LE, Lang GK. Calcium channel blockers and ocular carbodioxide reactivity in normal pressure glaucoma. X Congress Eur Soc of Ophthalmol 1995; 94.
Nethland P.A, Erickson K.A. Calcium channel blockers in glaucoma management. Ophthalmol Clin N Amer 1995; 2: 327–334.
Lin S, Araujo SV, Spaeth GL, Katz LJ, Smith M. Lack of effect of calcium channel blockers on open angle glaucoma. J Glaucoma 1996; 3: 187–190.
Santafe J, Martinez de Ibarreta MJ, Segarra J, Melena J. A longlasting hypotensive effect of topical diltiazen on the intraocular pressure in conscious rabbits. Naunyn-Schmiedeberg's Arch of Pharmacol 1997; 355(5): 645–650.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mikheytseva, I.N., Kashintseva, L.T., Krizhanovsky, G.N. et al. The Influence of the Calcium Channel Blocker Verapamil on Experimental Glaucoma. Int Ophthalmol 25, 75–79 (2004). https://doi.org/10.1023/B:INTE.0000031737.08988.b0
Issue Date:
DOI: https://doi.org/10.1023/B:INTE.0000031737.08988.b0